Back
Stoke Therapeutics, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
50
STOK
Stoke Therapeutics, Inc.
Last Price:
$30.59
Seasonality Move:
10.28%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atStoke Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 53.2% based on the past 6 years of stock performance.
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Stoke Therapeutics, Inc. Stock Undervalued?The current Stoke Therapeutics, Inc. [STOK] share price is $30.58. The Score for STOK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
STOK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Stoke Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 53.2% based on the past 6 years of stock performance.
Stoke Therapeutics, Inc. Stock Rating
Sell
50
Stoke Therapeutics, Inc. (STOK)
is a Sell
Is Stoke Therapeutics, Inc. overpriced?
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Stoke Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com
52-Week Data
52-Week High:
38.69
52-Week Low:
5.35
Prediction Charts
Market Cap:
1.7B
Price in USD:
30.58
Volume:
632K
Beta:
0.95
Technical Analysis
SMA50:
30.07
SMA100:
27.94
SMA200:
19.42
52-Wk Change:
242.83%
Stock Predictions
-
Is Stoke Therapeutics, Inc. stock public?Yes, Stoke Therapeutics, Inc. is a publicly traded company.
-
What is the Stoke Therapeutics, Inc. stock quote today?The Stoke Therapeutics, Inc. stock price is 30.58 USD today.
-
How to buy Stoke Therapeutics, Inc. stock online?You can buy Stoke Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-23 | 33.16 | 31.86 | 33.52 | 31.69 |
| Dec-24 | 31.73 | 32.17 | 32.80 | 31.68 |
| Dec-26 | 32.27 | 31.92 | 32.27 | 31.36 |
| Dec-29 | 31.56 | 32.18 | 32.33 | 31.00 |
| Dec-30 | 32.42 | 31.82 | 32.42 | 31.49 |
| Dec-31 | 31.68 | 31.74 | 32.50 | 31.45 |
| Jan-2 | 31.66 | 30.90 | 31.86 | 30.40 |
| Jan-5 | 30.71 | 32.55 | 32.67 | 29.75 |
| Jan-6 | 32.22 | 35.22 | 35.74 | 32.22 |
| Jan-7 | 35.84 | 35.17 | 37.34 | 35.09 |
| Jan-8 | 34.08 | 33.68 | 34.84 | 33.22 |
| Jan-9 | 33.91 | 32.85 | 34.34 | 32.46 |
| Jan-12 | 27.40 | 29.42 | 29.49 | 25.21 |
| Jan-13 | 29.01 | 30.58 | 30.63 | 28.27 |
Stoke Therapeutics, Inc. Earnings
Stoke Therapeutics, Inc. Earnings Report: Per Share Stoke Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Stoke Therapeutics, Inc. Forecast Revenue Growth
Stoke Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.21 per share, and an increase next year of $0.76 per share.
* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.